MACITENTAN for Pulmonary veno-occlusive disease: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 11 adverse event reports in the FDA FAERS database where MACITENTAN was used for Pulmonary veno-occlusive disease.

Most Reported Side Effects for MACITENTAN

Side Effect	Reports	%	Deaths	Hosp.
Dyspnoea	8,315	18.4%	1,685	5,903
Death	5,864	12.9%	5,789	2,120
Headache	4,856	10.7%	575	2,694
Diarrhoea	3,669	8.1%	574	2,268
Pneumonia	3,531	7.8%	810	3,162
Nausea	3,463	7.6%	456	2,116
Hospitalisation	3,414	7.5%	500	3,372
Fatigue	3,172	7.0%	485	1,899
Fluid retention	2,861	6.3%	575	2,150
Dizziness	2,704	6.0%	337	1,673
Malaise	2,521	5.6%	431	1,590
Pulmonary arterial hypertension	2,390	5.3%	1,204	1,695
Hypotension	2,318	5.1%	519	1,691
Cough	2,294	5.1%	314	1,404
Condition aggravated	2,198	4.9%	638	1,538